netFormulary
 Report : A-Z HCD items in Formulary 27/11/2020 00:11:00
[Back]
 
Section Status HCD Name
08.01.05 Restricted Use Cancer Drugs Fund Abemaciclib Verzenios®
02.12 Restricted Use Cancer Drugs Fund Alirocumab Praluent®
05.02 Restricted Use Cancer Drugs Fund Amphotericin IV Infusion 50mg AmBisome®
13.05.03 Restricted Use Cancer Drugs Fund Apremilast tablets Otezla®
08.01.05 Restricted Use Cancer Drugs Fund Atezolizumab Tecentriq®
10.01.03 Restricted Use Cancer Drugs Fund Baricitinib tablets Olumiant®
08.01.05 Restricted Use Cancer Drugs Fund Bevacizumab Avastin®
08.01.05 Formulary Cancer Drugs Fund Bortezomib Injection 3.5mg Velcade®
08.01.05 Restricted Use Cancer Drugs Fund Brentuximab vedotin injection 50mg Adcetris®
08.01.05 Restricted Use Cancer Drugs Fund Brigatinib Alunbrig®
10.01.03 Formulary Cancer Drugs Fund Brodalumab 210mg/1.5ml solution for injection pre-filled syringes  Kyntheum®
03.04.03 Restricted Use Cancer Drugs Fund C1 - Esterase Inhibitor Berinert®
04.08.01 Non Formulary Cancer Drugs Fund Cannabidiol oral solution 100mg/1ml Epidyolex®
05.02 Restricted Use Cancer Drugs Fund Caspofungin IV Infusion 50mg and 70mg Cancidas®
08.01.05 Restricted Use Cancer Drugs Fund Ceritinib Zykada
08.02 Restricted Use Cancer Drugs Fund Cladribine tablets Mavenclad®
05.01.07 Restricted Use Cancer Drugs Fund Colistimethate Sodium 1,662,500 unit inhalation powder capules Colobreathe®
05.01.07 Non Formulary Cancer Drugs Fund Colistimethate Sodium 1 million International Units Powder for Nebuliser Solution  Promixin®
05.03.03.02 Restricted Use Cancer Drugs Fund Daclatasvir 30mg & 60mg tablets Daklinza®
08.02.03 Restricted Use Cancer Drugs Fund Daratumumab Darzalex®
09.01.03 Restricted Use Cancer Drugs Fund Deferasirox Exjade®
09.01.03 Restricted Use Cancer Drugs Fund Deferiprone Ferriprox®
09.01.03 Restricted Use Cancer Drugs Fund Desferrioxamine Mesilate Injection 500mg 
18 Formulary Cancer Drugs Fund Digoxin-specific antibody Digifab®
13.05.02 Restricted Use Cancer Drugs Fund Dimethyl fumarate 30mg and 120mg tablets Skilarence®
05.03.03.02 Restricted Use Cancer Drugs Fund Elbasvir 50mg with grazoprevir 100mg tablets Zepatier®
08.01.05 Restricted Use Cancer Drugs Fund Eribulin Injection Halaven®
08.01.05 Restricted Use Cancer Drugs Fund Erlotinib Tarceva®
02.12 Restricted Use Cancer Drugs Fund Evolocumab Repatha®
04.06 Restricted Use Cancer Drugs Fund Fremanezumab Ajovy
08.01.05 Restricted Use Cancer Drugs Fund Gefitinib Tablets 250mg Iressa®
08.02.03 Restricted Use Cancer Drugs Fund Gemtuzumab ozogamicin 5mg powder for concentrate for solution for infusion Mylotarg®
05.03.03.02 Non Formulary Cancer Drugs Fund Glecaprevir with pibrentasvir 100mg/40mg tablets  Maviret®
10.01.03 Formulary Cancer Drugs Fund Guselkumab solution for injection 100mg Tremfya®
05.03.01 Restricted Use Cancer Drugs Fund HIV Post Exposure Prophylaxis Pack (PEP) 
08.01.05 Restricted Use Cancer Drugs Fund Ibrutinib capsules 140mg Imbruvica®
08.01.05 Non Formulary Cancer Drugs Fund Irinotecan hydrochloride trihydrate (as irinotecan sucrosofate salt in a pegylated liposomal formulation) Onivyde®
08.01.05 Restricted Use Cancer Drugs Fund Ixazomib Ninlaro®
13.05.03 Restricted Use Cancer Drugs Fund Ixekizumab injection 80mg Taltz®
03.04.03 Restricted Use Cancer Drugs Fund Lanadelumab injection 300mg/2ml Takhzyro®
08.03.04.03 Restricted Use Cancer Drugs Fund Lanreotide Somatuline Autogel®
08.03.04.03 Non Formulary Cancer Drugs Fund Lanreotide Somatuline® LA
05.03.03.02 Restricted Use Cancer Drugs Fund Ledipasvir/sofosbuvir 90/400mg tablets Harvoni®
08.01.05 Non Formulary Cancer Drugs Fund Lenvatinib Kisplyx®
02.03.02 Restricted Use Cancer Drugs Fund Mexiletine hydrochloride capsules (corresponding to 166.62 mg mexiletine) Namuscla®
08.01.05 Non Formulary Cancer Drugs Fund Midostaurin capsules 25mg Rydapt®
08.01.05 Formulary Cancer Drugs Fund Neratinib 
08.01.05 Restricted Use Cancer Drugs Fund Nintedanib Vargatef®
08.01.05 Restricted Use Cancer Drugs Fund Nivolumab Opdivo®
08.03.04.03 Restricted Use Cancer Drugs Fund Octreotide Sandosatin Lar®
08.02.04 Restricted Use Cancer Drugs Fund Olaparib 50mg capsules Lynparza®
05.03.03.02 Restricted Use Cancer Drugs Fund Ombitasvir/paritaprevir/ritonavir 12.5/75/50mg tablets Viekirax®
08.01.05 Restricted Use Cancer Drugs Fund Palbociclib Ibrance®
08.01.05 Restricted Use Cancer Drugs Fund Panitumumab infusion 100mg/5ml and 400mg/20ml Vectibix®
08.01.05 Restricted Use Cancer Drugs Fund Pembrolizumab infusion Keytruda®
08.01.05 Restricted Use Cancer Drugs Fund Pertuzumab 420mg/14ml concentrate for solution for infusion  Perjeta®
08.02.04 Restricted Use Cancer Drugs Fund Pomalidomide Imnovid®
05.02 Restricted Use Cancer Drugs Fund Posaconazole Noxafil®
11.08.02 Restricted Use Cancer Drugs Fund Ranibizumab Lucentis®
08.01.05 Restricted Use Cancer Drugs Fund Ribociclib Kisqali®
08.02.04 Restricted Use Cancer Drugs Fund Rucaparib tablets Rubraca®
05.03.03.02 Restricted Use Cancer Drugs Fund Simeprevir 400mg tablets Olysio®
05.03.03.02 Restricted Use Cancer Drugs Fund Sofosbuvir 150mg capsules Sovaldi®
05.03.03.02 Restricted Use Cancer Drugs Fund Sofosbuvir 400mg/velpatasvir 100mg tablets Epclusa®
05.03.03.02 Non Formulary Cancer Drugs Fund Sofosbuvir with velpatasvir and voxilaprevir Vosevi®
10.01.03 Restricted Use Cancer Drugs Fund Tofacitinib tablets 5mg Xeljanz®
06.05.02 Non Formulary Cancer Drugs Fund Tolvaptan Samsca®
06.05.02 Non Formulary Cancer Drugs Fund Tolvaptan 15mg, 30mg & 60mg tablets Jinarc®
08.01.05 Non Formulary Cancer Drugs Fund Trametinib Mekinist®
08.01.05 Restricted Use Cancer Drugs Fund Trifluridine with tipiracil tablets Lonsurf®
01.05.03 Restricted Use Cancer Drugs Fund Vedolizumab 300mg concentrate for infusion Entyvio®
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto®
08.01.05 Non Formulary Cancer Drugs Fund Vismodegib Erivedge®
Kettering General Hospital